Immediate Impact
57 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Long COVID: a clinical update
2024 Standout
Works of Toru Kiguchi being referenced
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
2022
Life-threatening bleeding and acquired factor V deficiency associated with primary systemic amyloidosis
2002
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Toru Kiguchi | 122 | 159 | 49 | 147 | 45 | 413 | |
| Umut Dişel | 107 | 152 | 54 | 145 | 46 | 459 | |
| Yaozhong Zhao | 91 | 181 | 62 | 144 | 47 | 395 | |
| G Mathé | 70 | 119 | 43 | 170 | 48 | 382 | |
| Mohamed Mabed | 104 | 125 | 61 | 88 | 37 | 384 | |
| Hitoji Uchiyama | 126 | 106 | 35 | 89 | 57 | 414 | |
| Hyewon Lee | 210 | 123 | 83 | 147 | 38 | 406 | |
| Nishant Tageja | 206 | 182 | 112 | 163 | 33 | 502 | |
| Clifton C. Mo | 230 | 206 | 69 | 170 | 44 | 463 | |
| M. Westerhausen | 72 | 114 | 45 | 206 | 50 | 420 | |
| Ioannis V. Kostopoulos | 207 | 249 | 74 | 150 | 60 | 510 |
All Works
Login with ORCID to disown or claim papers
Loading papers...